Canada markets closed

Structure Therapeutics Inc. (GPCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
36.15+0.27 (+0.75%)
At close: 04:00PM EDT
36.15 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.69B
Enterprise Value 1.25B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 347.79%
S&P500 52-Week Change 326.49%
52 Week High 375.02
52 Week Low 323.73
50-Day Moving Average 338.53
200-Day Moving Average 343.96

Share Statistics

Avg Vol (3 month) 3589.16k
Avg Vol (10 day) 3463.69k
Shares Outstanding 546.62M
Implied Shares Outstanding 646.39M
Float 8115.22M
% Held by Insiders 16.77%
% Held by Institutions 196.38%
Shares Short (Apr 30, 2024) 44.29M
Short Ratio (Apr 30, 2024) 49.62
Short % of Float (Apr 30, 2024) 411.40%
Short % of Shares Outstanding (Apr 30, 2024) 49.19%
Shares Short (prior month Mar 28, 2024) 43.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.16%
Return on Equity (ttm)-33.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -102.46M
Net Income Avi to Common (ttm)-89.62M
Diluted EPS (ttm)-2.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)467.32M
Total Cash Per Share (mrq)3.34
Total Debt (mrq)5.45M
Total Debt/Equity (mrq)1.20%
Current Ratio (mrq)19.14
Book Value Per Share (mrq)9.76

Cash Flow Statement

Operating Cash Flow (ttm)-79.49M
Levered Free Cash Flow (ttm)-51.38M